International Scholarly Research Notices / 2011 / Article / Tab 3

Clinical Study

Evaluating the Association between Assisted Conception and the Severity of Preeclampsia

Table 3

Demographics within preeclamptics.

VariableAssisted†  % ( 𝑁 = 1 6 )Unassisted‑  % ( 𝑁 = 4 2 4 ) 𝑃 value

Mean age37.3 +/βˆ’ 526.4 +/βˆ’ 6.7<0.001
Race (African American)18.8 (3)87.3 (370)<0.0001
Mean BMI at screening27.8 +/βˆ’ 6.830 +/βˆ’ 80.31
Primiparous75 (12)50.5 (214)0.095
Gestational age at delivery33.8 +/βˆ’ 4.236.1 +/βˆ’ 3.70.01
Twin pregnancy56.3 (9)3.1 (13)<0.0001
Pregestational diabetes04.3 (18)0.84
Gestational diabetes6.3 (1)3.8 (16)0.88
Chronic hypertension6.3 (1)15.8 (67)0.49
History of preeclampsia18.8 (3)21.0 (89)0.93
History of preterm preeclampsia6.3 (1)11.8 (50)0.78
Tobacco use012.5 (53)0.26

†Assisted pregnancies included use of clomiphene citrate, gonadotropins, IUI, IVF, ICSI, and donor egg,
‑Women with unassisted pregnancies did not report use of clomiphene citrate, gonadotropins, IUI, IVF, ICSI, or donor egg for conception.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.